Excel in a Demanding New Category
Both the promises and the challenges of biopharmaceuticals are enormous.
Tanvex BioPharma, Inc. is a modern pharmaceutical company in the clinical stage of commercial development. Led by Dr. Allen Chao, formerly founder and CEO of Watson Pharmaceuticals, Tanvex BioPharma is making new biopharmaceutical products more accessible.
Check out the latest news about Tanvex BioPharma and developments in the biopharmaceutical industry.
- Jan. 16, 2019 Tanvex submits NDS for TX01 to Health Canada
- Dec. 06, 2018 Tanvex BioPharma Attends ASHP
- Nov. 28, 2018 FDA Accepts TX01 BLA Filing
- Oct. 01, 2018 Tanvex BioPharma Submits its First Biologics License Application to U.S. FDA For TX-01